OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma
Junyu Huo, Liqun Wu, Yunjin Zang
Journal of Cellular and Molecular Medicine (2020) Vol. 25, Iss. 2, pp. 1151-1165
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

USP33 enhances cell survival and stemness by deubiquitinating CTNNB1 in BXPC‐3 and SW1990 cells
Bo Zhong, Qiaozhen Zhu, Linpei Wang, et al.
Cell Biology International (2023) Vol. 47, Iss. 8, pp. 1368-1380
Closed Access | Times Cited: 2

A Novel Caffeoylquinic Acid from Lonicera japonica Exerts Cytotoxic Activity by Blocking the YAP-CTGF Signaling Pathway in Hepatocellular Carcinoma
Wanying Shen, Xiaofang Wei, Yangfang Li, et al.
Revista Brasileira de Farmacognosia (2023) Vol. 33, Iss. 4, pp. 736-746
Open Access | Times Cited: 2

A novel tumor 4-driver gene signature for the prognosis of hepatocellular carcinoma
Houtian Guo, Fei Lu, Rongqi Lu, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17054-e17054
Open Access | Times Cited: 2

Identification of key biomarkers in hepatocellular carcinoma induced by non-alcoholic Steatohepatitis or metabolic syndrome via integrated bioinformatics analysis
Bing Wang, Yiqing Zhang, Lin Gai, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 7, pp. 174-180
Open Access | Times Cited: 2

Therapeutic targets and molecular mechanisms of Huangqin decoction in liver cancer: a network pharmacology and molecular docking approach
Ting Lan, Juan Wang, Ronghao Zeng, et al.
Journal of Herbal Medicine (2023) Vol. 43, pp. 100822-100822
Closed Access | Times Cited: 2

Integrated analysis of transcriptomics and metabolomics in human hepatocellular carcinoma HepG2215 cells after YAP1 knockdown
Yuting Gao, Yi Gong, Yiwei Liu, et al.
Acta Histochemica (2022) Vol. 125, Iss. 1, pp. 151987-151987
Closed Access | Times Cited: 3

Enhancing inhibitory effect in SMMC-7721 hepatoma cells through combined treatment of gallic acid and hUC-MSCs-Exos
Qiang Zhang, Liying Han, Xi Luo, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113704-113704
Closed Access

GENETIC MECHANISMS OF HEPATOCELLULAR CARCINOMA: LITERATURE REVIEW
A. Amirkulova, Gulmira Derbissalina, Nasrulla Shanazarov, et al.
Oncologia i radiologia Kazakhstana (2024) Vol. 71, Iss. 1, pp. 46-50
Open Access

Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection
Zhijun Zhang, Bajin Wei, Zhikun Liu, et al.
Hepatobiliary & pancreatic diseases international (2024)
Closed Access

Prognostic significance of LRRC1 in hepatocellular carcinoma and construction of relevant prognostic model
Qingshan Cai, Dongyang Wu, Yueling Shen, et al.
Medicine (2023) Vol. 102, Iss. 30, pp. e34365-e34365
Open Access | Times Cited: 1

N6-methyladenosine methylation-related genes YTHDF2, METTL3, and ZC3H13 predict the prognosis of hepatocellular carcinoma patients
Yun Wang, Tianjun Li, Haiping Liu, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1398-1398
Open Access | Times Cited: 2

Disulfidptosis-related lncRNAs predict prognosis and immune response of Liver hepatocellular carcinoma
Cheng Li, Donghui Xing, Kaiping Luo, et al.
Research Square (Research Square) (2023)
Open Access

Establishment and Validation of LncRNA Prognostic Indicators Related to Tertiary Lymphoid Structure in Hepatocellular Carcinoma
文 石
Advances in Clinical Medicine (2023) Vol. 13, Iss. 10, pp. 15504-15516
Closed Access

DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer
Zhen Shang, Ze Wang, Yongtao Zhang, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 10, pp. 2781-2805
Open Access

Previous Page - Page 2

Scroll to top